• CALL US: 602-843-2991
Arizona Asthma and Allergy Institute
  • Home
  • Our Providers
  • Our Services
    • First Office Visit
    • Allergy Testing
    • Allergy Injections
    • Allergy Drops
    • Rhinoscopy
    • Skin Biopsy Allergy Testing
    • Biological Medications
  • Patient Forms
  • Resources
    • After Hours On-Call Procedures
    • Conditions & Symptoms
    • Training and Education
    • FAQ
    • Health Insurance
    • Links You May Find Helpful
    • News
  • Locations and Hours
  • Schedule Appointment
  • Pay My Bill
  • Patient Portal
  • Click to open the search input field Click to open the search input field Search
  • Menu Menu
You are here: Home1 / News2 / AAAI News

Do you deal with asthma and allergies in Arizona? Read more from our doctors and other resources about food allergies, pharmaceutical trends and more.

AAAI News

Practicing in Allergy, Asthma and Immunology

After first practicing in primary care, Susan Symington, PA-C is the President of the American Academy of Physician Assistants in Allergy, (Asthma and Immunology effective July 2013).thought she knew a lot about allergies.  it wasn’t until she decided to specialize in allergy, asthma and immunology and began working at the Arizona Asthma and Allergy Institute in Glendale that she realized just how severe allergies and asthma can be – and what a difference proper diagnosis and treatment can make for these patients.  Read More Click Here

https://azsneeze.com/wp-content/uploads/2023/10/AAAI_Logo_Updated.png 0 0 AZSneeze https://azsneeze.com/wp-content/uploads/2023/10/AAAI_Logo_Updated.png AZSneeze2013-04-16 21:33:072013-04-16 21:33:07Practicing in Allergy, Asthma and Immunology
AAAI News

Primary Immunodeficiencies – Recognition and screening strategies

Immunodeficiencies are inherited disorders.  About 60% of cases are detected in childhood, and the remaining 40% are detected in adults.  Immunodeficiencies were long considered uncommon, but that perception is changing.  More than 200 primary immunodeficiencies have been classified.  Read more Click Here

https://azsneeze.com/wp-content/uploads/2023/10/AAAI_Logo_Updated.png 0 0 AZSneeze https://azsneeze.com/wp-content/uploads/2023/10/AAAI_Logo_Updated.png AZSneeze2013-04-15 20:24:002013-04-15 20:24:00Primary Immunodeficiencies – Recognition and screening strategies
AAAI News, Helpful Resources

Epinephrine in schools makes sense

SB1421, which will allow Arizona schools to stock epinephrine for use during emergency situations, is introduced at an ideal time and could save lives.

Food allergy is on the rise, with 6 million children estimated to have food allergies in America. It is alarming that 25 percent of all episodes of food induced allergic reactions at school occur without the child or parent knowing they were allergic to a particular food. I have heard the personal stories of patients and parents who had close calls with their children after a severe allergic reaction. Some were because of a particular food, others because of an insect sting or medication. All live with the realization that exposure to some allergens have potential fatal consequences.

This was the unfortunate outcome just last year in Virginia where first grader Ammaria Johnson died after a severe (anaphylactic) reaction to peanut ingestion at school. Here in Arizona, Anna Aguirre, once a perfectly healthy teenager, had anaphylactic shock after eating cereal containing nuts. She survived a coma but continues to have ongoing disability. In both cases intervention with medication could have altered the outcomes of these children. As a physician, I support the passage of SB1421 because conceivably it assures that potential life saving treatment is available during unexpected and severe reactions. I believe that with access to medication, disability and even death from food induced allergic reactions among students could be prevented. For children, epinephrine is proven to be very safe and highly effective in treating severe allergic reactions.

To that end, SB1421 is well thought out. It accounts for training of school personnel on how to recognize an allergic reaction as well as how to use the auto-injector. Epinephrine auto-injectors are easy to use and easy to train on their use. The signs and symptoms of when to use an epinephrine injector are also easy to describe and list. Furthermore, the bill includes a “Good Samaritan” provision, freeing school personnel to focus on doing what is right for the child.

It is also important to note that local organizations like the Arizona Food Allergy Alliance have been collaborating on the bill’s language and providing pertinent information, including details about programs that provide epinephrine auto-injectors at no cost to schools. This should be fully explored. Furthermore, SB1421 makes sense because it is known that schools are higher risk areas for exposure, as up to 18 percent of children with known food allergies have had accidental exposures at school.

I hope lawmakers support SB1421. It is a step toward better protecting our children. There will always be many cases of children having reactions without already having an established diagnosis of food allergy. And even with appropriately diagnosing children with a specific food allergy and trying to follow strict avoidance strategies there will always be risk of accidental
exposures.

We can’t ignore the fact that food allergy is on the rise and having better access to treatment for life threatening reactions is crucial to the safety of our children. What better place to start this awareness and improve safety than at our schools.

— Dr. Levente E. Erdos is a board certified allergist and 2012 president of the Arizona Asthma and Allergy Institute, the largest specialty provider of allergy care in Arizona.

https://azsneeze.com/wp-content/uploads/2023/10/AAAI_Logo_Updated.png 0 0 AZSneeze https://azsneeze.com/wp-content/uploads/2023/10/AAAI_Logo_Updated.png AZSneeze2013-03-22 16:13:282013-03-22 16:13:28Epinephrine in schools makes sense
AAAI News

Is your asthma under control?

It is important to be able to identify that your asthma is out of control as well as find the best treatment to manage your symptoms. There are safe and effective treatments that can relieve you of of your uncontrolled symptoms of asthma and help you to carry on with your daily life.

The first step is to realize that your asthma is not under control. The following is a list of potential indicators that your asthma needs better management.

  • If you are having asthma symptoms like coughing, wheezing, or shortness of breath during the day more than four days per week.
  • If your asthma is waking you up at night.
  • If you have recently missed school or work because of your asthma.
  • If you have cut back on your usual activities because of my asthma
  • If you have recently gone to the emergency room or spent time in the hospital because of your asthma.
  • If you need to use your reliever medication (a fast-acting asthma medication that quickly relieves symptoms) four or more times per week (not counting puffs taken before exercise)
  • If you have experienced any unwanted effects from my asthma medications
  • If you use a peak flow meter (a device that helps you measure your lung function), and your peak flow meter readings have been getting worse.
  • If there have been any changes in your routine or environment lately (e.g., getting a pet, spending more time around smokers).

At Arizona Asthma and Allergy Institute, our doctors are experienced in the diagnosis and management of uncontrolled asthma and we want to help you to experience the relief that you need. Learn more here about what happens during an asthma attack. Call one of our offices today and feel better!

https://azsneeze.com/wp-content/uploads/2023/10/AAAI_Logo_Updated.png 0 0 AZSneeze https://azsneeze.com/wp-content/uploads/2023/10/AAAI_Logo_Updated.png AZSneeze2012-04-19 15:07:592012-04-19 15:07:59Is your asthma under control?
AAAI News

FDA approves FENO Niox

NIOX MINO®, a hand-held device for the measurement of airway inflammation and monitoring of patients with asthma, has just been 510(k) cleared by the FDA. NIOX MINO, a product of Swedish company Aerocrine AB, is designed to measure fractional exhaled nitric oxide (FENO), an inflammatory marker. The company promotes its product as a device that will “cost efficiently improve management and care of patients with inflammatory disorders, such as asthma.” The monitor is sensitive enough to detect as low as 5 particles per billion of exhaled nitric oxide. Read more here.

At Arizona Asthma and Allergy Institute, we are now using this new technology to further evaluate and manage asthma.

https://azsneeze.com/wp-content/uploads/2023/10/AAAI_Logo_Updated.png 0 0 AZSneeze https://azsneeze.com/wp-content/uploads/2023/10/AAAI_Logo_Updated.png AZSneeze2012-03-13 20:50:512012-03-13 20:50:51FDA approves FENO Niox
AAAI News

Gilbert office moves across the street

Our Gilbert location has moved across the street to Mesa to better serve you. The new address is: 4140 E. Baseline Rd # 112
Mesa, AZ 85206 – If you have any questions, please call our office at 602-843-2991

https://azsneeze.com/wp-content/uploads/2023/10/AAAI_Logo_Updated.png 0 0 AZSneeze https://azsneeze.com/wp-content/uploads/2023/10/AAAI_Logo_Updated.png AZSneeze2011-10-29 15:42:262011-10-29 15:42:26Gilbert office moves across the street
AAAI News

What is the “Pneumonia Shot” and who should get it?

The “Pneumonia Shot” as it is commonly referred is a vaccine that helps protect against infection from the bacteria Streptococcus pneumoniae. This is one of the most common bacterias to cause Pneumonia, Bronchitis or Sinusitis.

Do you know that the guidelines recommend this vaccine for anyone with Asthma 19 years and older?  Read below for further information about this vaccine and who should receive:

Vaccination with pneumococcal polysaccharide vaccine (PPSV) is recommended for all people who meet any of the criteria below:

  1. Previously unvaccinated adults age 65 years and older
  2. Age 2 through 64 with any of the following conditions:
  • Chronic pulmonary disease (including athma in people age 19 years and older)
  • Cigarette smokers 19 years and older
  • Chronic cardiovascular disease
  • Immunocompromising conditions
  • Diabetes mellitus
  • Chronic kidney disease
  • Alcoholism or chronic liver disease
https://azsneeze.com/wp-content/uploads/2023/10/AAAI_Logo_Updated.png 0 0 AZSneeze https://azsneeze.com/wp-content/uploads/2023/10/AAAI_Logo_Updated.png AZSneeze2011-10-19 17:25:142011-10-19 17:25:14What is the “Pneumonia Shot” and who should get it?
AAAI News

Primatene Mist discontinued over the counter

The FDA has ordered Primatene Mist, the only over-the-counter asthma inhaler, be taken off drugstore shelves December 31st.  Primatene Mist has CFC’s which is not environmentally safe as this can deplete the earth’s ozone layer.  Several other products with CFC’s have already been removed from the market for the same reasons.

AAAI Physicians do not endorse Primatene Mist for asthma treatment because this is no longer the standard of care for asthma and the epinephrine in this medication has harmful side effects if over used.  There are safer and more appropriate medications for asthma treatment.

We feel this will improve patient care by decreasing adverse effects from this medication.  This will also encourage patients to see their physician to discuss their symptoms and have appropriate evaluation and treatment.

https://azsneeze.com/wp-content/uploads/2023/10/AAAI_Logo_Updated.png 0 0 AZSneeze https://azsneeze.com/wp-content/uploads/2023/10/AAAI_Logo_Updated.png AZSneeze2011-09-28 21:28:462011-09-28 21:28:46Primatene Mist discontinued over the counter
AAAI News

Insect Sting Allergy

Insect stings commonly cause local swelling, pain, itching and redness at the site of the sting.  Many people who have an allergy to insect venom have these same symptoms but causing much larger reactions that can persist for days.  Up to 3-4% of Adults and 1% of Children in the general population have an allergy to insects that cause more serious “systemic reactions”.  Systemic reactions will not only cause large local reactions at the site of the sting but also can cause diffuse hives, trouble breathing and possibly life threatening symptoms such as throat swelling and anaphylactic shock.  The most common insect allergies to cause these types of reactions are from Bee and Fire Ant stings.

Here at the Arizona Asthma and Allergy Institute we have accurate testing to evaluate those at risk for these potentially serious reactions to insect stings.  Patients with a known history of serious reactions to Bees or Fire Ants can qualify for allergy injections which can be 98% effective in preventing a systemic reaction to future stings.  If you have any questions or want further investigation on your risk of insect allergy then our providers can help you!

https://azsneeze.com/wp-content/uploads/2023/10/AAAI_Logo_Updated.png 0 0 AZSneeze https://azsneeze.com/wp-content/uploads/2023/10/AAAI_Logo_Updated.png AZSneeze2011-09-21 18:51:012011-09-21 18:51:01Insect Sting Allergy
AAAI News

Eczema and Food Allergy

The onset of eczema frequently coincides with introduction of certain foods into the infant’s diet.  Common food allergies and possible triggers to eczema in children include egg, milk, peanut, soy and wheat.  Overall, about 20-30% of children with eczema have food allergies to one or more of these foods.

If your child has eczema there may be an underlying food allergy contributing.  We can further evaluate this to see if foods are a trigger to your child’s eczema and avoiding the food allergen(s) can have a significant benefit in improving eczema.

https://azsneeze.com/wp-content/uploads/2023/10/AAAI_Logo_Updated.png 0 0 AZSneeze https://azsneeze.com/wp-content/uploads/2023/10/AAAI_Logo_Updated.png AZSneeze2011-09-12 23:32:162011-09-12 23:32:16Eczema and Food Allergy
Page 4 of 512345

Categories

  • AAAI News
  • Allergen Immunotherapy
  • Featured
  • Helpful Resources
  • News
  • Podcasts
  • Uncategorized

Facebook

Resources

Our Providers

Patient Forms

Training & Education

Careers

New Patient Appointments

Policies

Office Policies

Privacy Policies

Insurances

POLLEN COUNT

Get a custom report of the pollen count in your area.
 

Stay Connected

News

© Copyright - Arizona Asthma and Allergy Institute    Site by COR
NOTICE OF PRIVACY PRACTICES
LANGUAGE ASSISTANCE INFORMATION: ENGLISH | ESPAÑOL (SPANISH) | TIẾNG VIỆT (VIETNAMESE) | 繁體中文 (CHINESE) | DEUTSCH (GERMAN) |
한국어 (KOREAN) | ໄທລາວ (LAOTIAN) | TAGALOG (TAGALOG – FILIPINO) | FRANÇAIS (FRENCH) | 日本語 (JAPANESE) | РУССКИЙ (RUSSIAN) | فارسی (FARSI) | KISWAHILI (SWAHILI)
    Scroll to top Scroll to top Scroll to top

    This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

    OK

    Cookie and Privacy Settings



    How we use cookies

    We may request cookies to be set on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience, and to customize your relationship with our website.

    Click on the different category headings to find out more. You can also change some of your preferences. Note that blocking some types of cookies may impact your experience on our websites and the services we are able to offer.

    Essential Website Cookies

    These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

    Because these cookies are strictly necessary to deliver the website, refusing them will have impact how our site functions. You always can block or delete cookies by changing your browser settings and force blocking all cookies on this website. But this will always prompt you to accept/refuse cookies when revisiting our site.

    We fully respect if you want to refuse cookies but to avoid asking you again and again kindly allow us to store a cookie for that. You are free to opt out any time or opt in for other cookies to get a better experience. If you refuse cookies we will remove all set cookies in our domain.

    We provide you with a list of stored cookies on your computer in our domain so you can check what we stored. Due to security reasons we are not able to show or modify cookies from other domains. You can check these in your browser security settings.

    Google Analytics Cookies

    These cookies collect information that is used either in aggregate form to help us understand how our website is being used or how effective our marketing campaigns are, or to help us customize our website and application for you in order to enhance your experience.

    If you do not want that we track your visit to our site you can disable tracking in your browser here:

    Other external services

    We also use different external services like Google Webfonts, Google Maps, and external Video providers. Since these providers may collect personal data like your IP address we allow you to block them here. Please be aware that this might heavily reduce the functionality and appearance of our site. Changes will take effect once you reload the page.

    Google Webfont Settings:

    Google Map Settings:

    Google reCaptcha Settings:

    Vimeo and Youtube video embeds:

    Other cookies

    The following cookies are also needed - You can choose if you want to allow them:

    Accept settingsHide notification only
    Important Insurance Notice for Banner Medicare Advantage Patients

    Important Insurance Notice

    For Banner Medicare Advantage Patients

     

    Arizona Asthma & Allergy Institute will no longer be in network with

    Banner Medicare Advantage plans after September 15, 2026.

     

    Affected Plans

    This notice applies to patients with:

    • Banner Medicare Advantage Prime HMO
    • Banner Medicare Advantage Plus PPO

    Important Date

    Contract end date: September 15, 2026

    After this date, Arizona Asthma & Allergy Institute will be out of network for these plans.

     

    What This Means for You

    • Prior authorizations do not guarantee payment after September 15, 2026.
    • You may be responsible for charges if services are received out of network.
    • You may choose to transition to an in-network allergy provider or continue

    care with AAAI as self-pay.

    Need help? Please speak with our staff if you have questions or need assistance reviewing your options.

     

    Arizona Asthma & Allergy Institute

    We are here to help you navigate your care during this transition.

    • English
    • Español